A synthetic peptide for use as a blocking control in assays to test for specificity of µgT8 antibody, Alternative Names: UGT8 control peptide, µgT8 antibody Blocking Peptide, Anti-UGT8 Blocking Peptide, Udp Glycosyltransferase 8 Blocking Peptide, CGT Blocking Peptide, µgT8, µgT-8, µgT 8, µgT-8 Blocking Peptide, µgT 8 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
UGT8
(UDP Glycosyltransferase 8 (UGT8))
Hintergrund
Galactocerebrosides are abundant sphingolipids of the myelin membrane of the central nervous system and peripheral nervous system and are also present in small amounts in kidney. The key enzymatic step in the biosynthesis of galactocerebrosides consists of the transfer of galactose to ceramide catalyzed by UDP-galactose ceramide galactosyltransferase. The enzyme UGT8 is the first involved in complex lipid biosynthesis in the myelinating oligodendrocyte.